零售商股

1,047.463

-2.675-0.25%

漲家數：3

跌家數：3

平家數：15

市盈率：- -

高：1,050.338

開：1,050.138

低：1,047.184

收：1,050.138

成交量：435.68萬

成交額：96.91萬

市值：87.61億

流通市值：21.69億

資料載入中...

總覽新聞資訊

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK6514/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK6514","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6514\",,,,,undefined,":{"symbol":"BK6514","market":"SI","secType":"PLATE","nameCN":"零售商股","latestPrice":1047.4629,"timestamp":1789463383117,"preClose":1050.1377,"halted":0,"volume":4356800,"delay":0,"changeRate":-0.002547,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-2.674805,"latestTime":"09-15 17:16:00 SGT","open":1050.1377,"high":1050.3383,"low":1047.1835,"amount":969111.3,"amplitude":0.003004,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789518600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789432200000,1789444800000],[1789448400000,1789463760000]],"pbRate":0.943195,"peRate":17.057051,"turnoverRate":0.000415,"increases":3,"decrements":3,"flats":17,"marketCap":8761305647,"floatMarketCap":2169463658.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6514\",,,,,undefined,":{"symbol":"BK6514","high":1050.3383,"amplitude":0.003004,"preClose":1050.1377,"low":1047.1835,"pbRate":"0.943195","latestPrice":1047.4629,"volume":4356800,"delay":0,"open":1050.1377,"prevYearClose":1110.3745,"prevWeekClose":1052.0084,"prevMonthClose":1013.3159,"prevQuarterClose":1051.4308,"fiveDayClose":1057.9946,"twentyDayClose":1034.3246,"sixtyDayClose":1079.3987,"secType":"PLATE","market":"SI","turnoverRate":0.000415,"peRate":17.057051,"marketCap":8761305647,"floatMarketCap":2169463658.75,"timestamp":1789463383117,"nameCN":"零售商股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK6514\",,,,undefined,":{"bkCode":"BK6514","up":3,"down":3,"flat":15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK6514\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667379653","title":"科倫博泰生物升逾3% POLARIS-1臨床試驗2期部分取得陽性結果 並已啓動3期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2667379653","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667379653?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:44","pubTimestamp":1789368240,"startTime":"0","endTime":"0","summary":"科伦博泰生物(06990)涨超3%，截至发稿，涨3.35%，报480.8港元，成交额2.53亿港元。消息面上，近日，科伦博泰生物发布公告，公司的合作方Windward Bio AG(Windward Bio)已公布SKB378/WI ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260914/c679874229.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260914/c679874229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["5BI.SI","BK6008","BK6514"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665967373","title":"和鉑醫藥：HBM9378/WIN378治療哮喘II期臨床取得陽性中期結果並啓動III期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2665967373","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665967373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:53","pubTimestamp":1788871980,"startTime":"0","endTime":"0","summary":"9月8日，和铂医药-B(02142.HK)合作伙伴Windward Bio AG公布，HBM9378/WIN378用于治疗哮喘的POLARIS-1临床试验II期部分取得阳性的中期结果，POLARIS-1的III期部分亦已启动。 HB ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260908/c679714030.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260908/c679714030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["5BI.SI","BK6008","BK6514"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665014320","title":"科倫博泰生物：SKB378/WIN378治療哮喘的2期臨床取得陽性結果及3期研究啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2665014320","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665014320?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":"9月8日，科伦博泰生物(06990.HK)发布公告，公司的合作方Windward Bio AG(Windward Bio)已公布SKB378/WIN378(一款靶向胸腺基质淋巴细胞生成素(TSLP)的全人源超长效单克隆抗体)用于治疗哮喘 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260908/c679711373.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260908/c679711373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["5BI.SI","BK6008","BK6514"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}

零售商股

科倫博泰生物升逾3% POLARIS-1臨床試驗2期部分取得陽性結果 並已啓動3期臨床

和鉑醫藥：HBM9378/WIN378治療哮喘II期臨床取得陽性中期結果並啓動III期研究

科倫博泰生物：SKB378/WIN378治療哮喘的2期臨床取得陽性結果及3期研究啓動

科倫博泰生物升逾3% POLARIS-1臨床試驗2期部分取得陽性結果並已啓動3期臨床